Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:Next oroboros ecosystem agenda"

From Bioblast
Line 10: Line 10:
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|'''"mtSrc-dependent reduction of mtDNA levels lead to OXPHOS deficiency and a more aggressive phenotype [of breast cancer]. Inhibitors specific for mtSrc could therefore restore mitochondrial activity in TNBC cells, and ultimately stop malignancy"''' <br>
|'''"mtSrc-dependent reduction of mtDNA levels lead to OXPHOS deficiency and a more aggressive phenotype [of breast cancer]. Inhibitors specific for mtSrc could therefore restore mitochondrial activity in TNBC cells, and ultimately stop malignancy"''' <br>
* Djeungoue-Petga MA, Lurette O, Jean S, Hamel-Côté G, Martín-Jiménez R, Bou M, Cannich A, Roy P, Hebert-Chatelain E (2019) Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells. Cell Death Dis 10:940. [[Djeungoue-Petga 2019 Cell Death Dis|»Bioblast link«]]
* Djeungoue-Petga MA, Lurette O, Jean S, Hamel-Côté G, Martín-Jiménez R, Bou M, Cannich A, Roy P, Hebert-Chatelain E (2019) Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells. [[Djeungoue-Petga 2019 Cell Death Dis|»Bioblast link«]]
:from the O2k-Network »[[CA Moncton Hebert-Chatelain E]]«  
:from the O2k-Network »[[CA Moncton Hebert-Chatelain E]]«  
|}
|}
Line 32: Line 32:
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|'''"Haplogroup D5 [risk factor of breast cancer] exhibited reduced mitochondrial OXPHOS function compared to that of the non-D5 haplogroups […] because of not only lower Complex I activity but also decreased Complex III activity"''' <br>
|'''"Haplogroup D5 [risk factor of breast cancer] exhibited reduced mitochondrial OXPHOS function compared to that of the non-D5 haplogroups […] because of not only lower Complex I activity but also decreased Complex III activity"''' <br>
* Ma L, Fu Q, Xu B, Zhou H, Gao J, Shao X, Xiong J, Gu Q, Wen S, Li F, Shen L, Chen G, Fang H, Lyu J (2017) Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation. Int J Cancer 142:1786-96. [[Ma 2017 Int J Cancer|»Bioblast link«]]
* Ma L, Fu Q, Xu B, Zhou H, Gao J, Shao X, Xiong J, Gu Q, Wen S, Li F, Shen L, Chen G, Fang H, Lyu J (2017) Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation. [[Ma 2017 Int J Cancer|»Bioblast link«]]
|}
|}
----
----

Revision as of 16:58, 17 October 2022


2022 Week 43
  • Oct-24 Mo
»CRUK Beatson Institute Workshop 2022 Glasgow UK« Oct 24-25

  • Oct-25 Tu- Breast Cancer Awareness Month
O2k-Publications in the MiPMap "mtSrc-dependent reduction of mtDNA levels lead to OXPHOS deficiency and a more aggressive phenotype [of breast cancer]. Inhibitors specific for mtSrc could therefore restore mitochondrial activity in TNBC cells, and ultimately stop malignancy"
  • Djeungoue-Petga MA, Lurette O, Jean S, Hamel-Côté G, Martín-Jiménez R, Bou M, Cannich A, Roy P, Hebert-Chatelain E (2019) Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells. »Bioblast link«
from the O2k-Network »CA Moncton Hebert-Chatelain E«

  • Oct-26 We
»13th Targeting Mitochondria Congress 2022 Berlin DE« Oct 26-28

  • Oct-27 Th

  • Oct-28 Fr
2022 Week 44
  • Oct-31 Mo- Breast Cancer Awareness Month
O2k-Publications in the MiPMap "Haplogroup D5 [risk factor of breast cancer] exhibited reduced mitochondrial OXPHOS function compared to that of the non-D5 haplogroups […] because of not only lower Complex I activity but also decreased Complex III activity"
  • Ma L, Fu Q, Xu B, Zhou H, Gao J, Shao X, Xiong J, Gu Q, Wen S, Li F, Shen L, Chen G, Fang H, Lyu J (2017) Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation. »Bioblast link«

  • Nov- 01 Tu

  • Nov- 02 We

  • Nov- 03 Th

  • Nov- 04 Fr

  • Nov-05 Sa
Abstract submission open for EUROMIT2023 Bologna IT

2022 Week 45
  • Nov- 07 Mo

  • Nov- 08 Tu

  • Nov- 09 We

  • Nov- 10 Th

  • Nov- 11 Fr
2022 Week 46
  • Nov- 14 Mo - World Diabetes Day
O2k-brief repository Mistimed eating, e.g., during shift-work, disrupts mitochondrial function and could contribute to type-2 diabetes mellitus
  • de Goede P, Wüst RCI, Schomakers BV, Denis S, Vaz FM, Pras-Raves ML, van Weeghel M, Yi CX, Kalsbeek A, Houtkooper RH (2022) Time-restricted feeding during the inactive phase abolishes the daily rhythm in mitochondrial respiration in rat skeletal muscle. »Bioblast link«
from the O2k-Network »NL Amsterdam Wuest RC«

  • Nov- 15 Tu

  • Nov- 16 We
»AussieMit 2022 Sydney AU« Nov 16-18

  • Nov- 17 Th - World Pancreatic Cancer Day



  • Nov- 18 Fr


2022 Week 47
  • Nov- 21 Mo

  • Nov- 22 Tu

  • Nov- 23 We

  • Nov- 24 Th

  • Nov- 25 Fr


2022 Week 48
  • Nov- 28 Mo

  • Nov- 29 Tu

  • Nov- 30 We

  • Dec- 01 Th

  • Dec- 02 Fr
2022 Week 49
  • Dec- 05 Mo

  • Dec- 06 Tu

  • Dec- 07 We

  • Dec- 08 Th

  • Dec- 09 Fr
2022 Week 50
  • Dec- 12 Mo

  • Dec- 13 Tu
»AlgaEurope 2022 Rome IT« Dec 13-15

  • Dec- 14 We

  • Dec- 15 Th

  • Dec- 16 Fr
2022 Week 51
  • Dec- 19 Mo

  • Dec- 20 Tu

  • Dec- 21 We

  • Dec- 22 Th

  • Dec- 23 Fr
2022 Week 52
  • Dec- 26 Mo

  • Dec- 27 Tu

  • Dec- 28 We

  • Dec- 29 Th

  • Dec- 30 Fr